Text

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA® in a Phase 1b Clinical Trial in Melanoma

The bacterial strains in MB097 were identified by analysing the microbiome of patients in multiple studies of ICIs in melanoma.

A gut microbe can promote growth in mice

The findings of a new study suggest that providing at-risk populations with NOD2 ligands or probiotic bacteria that release high levels of NOD2-activating molecules may help to treat undernutrition.

Microbiota-derived metabolite may help combat pancreatic cancer

The findings of a new study suggest that the microbial metabolite 3-IAA could help to treat PDAC.

Scioto Biosciences announces publication of Phase 1b study in autism

The first-in-human study double-blind, placebo controlled, 28-day crossover study of the safety and tolerability of SB-121

The impact of gut microbiome on child mental health

Collaborative initiatives would be needed to detect subtle associations and understand the role of the gut microbiome in the development of psychiatric symptoms over time.

Mouth bacteria may trigger rheumatoid arthritis flare-ups

The findings of a new study suggest that periodontal disease may contribute to rheumatoid arthritis by triggering specific immune responses.

Probiotics for female indications: Impact of Probi® probiotics for bone health support

Download the review that summarize the scientific and clinical work conducted on the probiotic formulation Probi® Osteo.

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy

Hepatic encephalopathy is a debilitating and recurring condition that causes neuropsychiatric conditions and is a common complication of cirrhosis.

Diet and environment drive the diversity of the infant gut virome

The findings of a new study suggest that infants acquire their gut virome from their diet and environment rather than from their mothers.

Pregnancy-induced changes to the gut microbiota may exacerbate inflammation

The findings of a new study reveal a microbe-immune axis that is disrupted in pregnant animals, suggesting potential therapeutic approaches for pregnancy-associated sepsis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top